Michael H. Baumann

21.2k total citations · 4 hit papers
324 papers, 15.4k citations indexed

About

Michael H. Baumann is a scholar working on Cellular and Molecular Neuroscience, Toxicology and Molecular Biology. According to data from OpenAlex, Michael H. Baumann has authored 324 papers receiving a total of 15.4k indexed citations (citations by other indexed papers that have themselves been cited), including 214 papers in Cellular and Molecular Neuroscience, 115 papers in Toxicology and 84 papers in Molecular Biology. Recurrent topics in Michael H. Baumann's work include Neurotransmitter Receptor Influence on Behavior (193 papers), Forensic Toxicology and Drug Analysis (115 papers) and Psychedelics and Drug Studies (81 papers). Michael H. Baumann is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (193 papers), Forensic Toxicology and Drug Analysis (115 papers) and Psychedelics and Drug Studies (81 papers). Michael H. Baumann collaborates with scholars based in United States, United Kingdom and Belgium. Michael H. Baumann's co-authors include Richard B. Rothman, John S. Partilla, Bruce E. Blough, Charlie Strange, Kenner C. Rice, Christina M. Dersch, Steven A. Sahn, Mario Ayestas, Richard W. Light and F. Ivy Carroll and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Michael H. Baumann

315 papers receiving 14.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Grading Strength of Recommendations and Quality of Evidence in Clinical Guidelines

2006 862 citations Michael H. Baumann et al. profile →
Management of Spontaneous Pneumothorax

2001 792 citations Michael H. Baumann, Charlie Strange et al. profile →
Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin

2000 744 citations Richard B. Rothman, Michael H. Baumann et al. profile →
Evidence for Possible Involvement of 5-HT_2BReceptors in the Cardiac Valvulopathy Associated With Fenfluramine and Other Serotonergic Medications

2000 541 citations Richard B. Rothman, Michael H. Baumann et al. profile →

Peers

Countries citing papers authored by Michael H. Baumann

Since Specialization

Citations

This map shows the geographic impact of Michael H. Baumann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael H. Baumann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael H. Baumann more than expected).

Fields of papers citing papers by Michael H. Baumann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael H. Baumann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael H. Baumann. The network helps show where Michael H. Baumann may publish in the future.

Co-authorship network of co-authors of Michael H. Baumann

This figure shows the co-authorship network connecting the top 25 collaborators of Michael H. Baumann. A scholar is included among the top collaborators of Michael H. Baumann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael H. Baumann. Michael H. Baumann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development and validation of an analytical method for the determination of select 4-position ring-substituted tryptamines in plasma by liquid chromatography–tandem mass spectrometry 2025 ·Journal of Analytical Toxicology ·(unknown), (unknown), (unknown), (unknown), David R. Manke, A.R. Chadeayne, Grant C. Glatfelter, Michael H. Baumann, Marta Concheiro	0
2	When a Prophecy comes True: Ethyleneoxynitazene as a ‘Prophetic’ Member of the Emerging Class of 2-Benzylbenzimidazole ‘Nitazene’ Synthetic Opioids 2024 ·SHILAP Revista de lepidopterología ·Marthe M. Vandeputte, (unknown), Donna Walther, István Ujváry, Donna M. Iula, Michael H. Baumann, Christophe P. Stove	0
3	In Vitro Functional Profiling of Fentanyl and Nitazene Analogs at the μ-Opioid Receptor Reveals High Efficacy for Gi Protein Signaling 2024 ·ACS Chemical Neuroscience ·(unknown), Li Chen, Michael H. Baumann, Meritxell Canals, Jonathan A. Javitch, J. Robert Lane, Lei Shi	16
4	Comparative Pharmacological Effects of Lisuride and Lysergic Acid Diethylamide Revisited 2024 ·ACS Pharmacology & Translational Science ·Grant C. Glatfelter, Eline Pottie, John S. Partilla, Christophe P. Stove, Michael H. Baumann	17
5	Elucidating the harm potential of brorphine analogues as new synthetic opioids: Synthesis, in vitro, and in vivo characterization 2024 ·Neuropharmacology ·Marthe M. Vandeputte, Sabrine Bilel, Micaela Tirri, (unknown), M. Bassi, (unknown), Anna Fantinati, Donna Walther, Donna M. Iula, Michael H. Baumann, Christophe P. Stove, Matteo Marti	5
6	Near-optimal performance of stochastic economic MPC 2024 ·(unknown), (unknown), Timm Faulwasser, Michael H. Baumann, Lars Grüne	0
7	Unique pharmacodynamic properties and low abuse liability of the µ-opioid receptor ligand (S)-methadone 2023 ·Molecular Psychiatry ·Marjorie R. Levinstein, Paulo Alexandre de Oliveira, (unknown), César Quiroz, (unknown), Rana Rais, William Rea, (unknown), (unknown), Verònica Casadó-Anguera, Estefanía Moreno, Donna Walther, Grant C. Glatfelter, David Weinshenker, Carlos A. Zarate, Vicent Casadó, Michael H. Baumann, Leonardo Pardo, Sergi Ferré, Michael Michaelides	7
8	Subtle Structural Modification of a Synthetic Cannabinoid Receptor Agonist Drastically Increases its Efficacy at the CB1 Receptor 2023 ·ACS Chemical Neuroscience ·Hideaki Yano, (unknown), (unknown), Phuong T. Tran, Alexander F. Hoffman, Michael H. Baumann, Carl R. Lupica, Lei Shi	4
9	Characterization of the Native Disulfide Isomers of the Novel χ-Conotoxin PnID: Implications for Further Increasing Conotoxin Diversity 2023 ·Marine Drugs ·Michael J. Espiritu, (unknown), (unknown), (unknown), Nikolaus M. Loening, (unknown), (unknown), Michael H. Baumann, Jon‐Paul Bingham	3
10	Persistent binding at dopamine transporters determines sustained psychostimulant effects 2023 ·Proceedings of the National Academy of Sciences ·Marco Niello, (unknown), (unknown), (unknown), (unknown), Julian Maier, (unknown), Walter Sandtner, (unknown), Carl R. Lupica, Alexander F. Hoffman, Gert Lübec, Claus J. Løland, Thomas Stockner, Daniela D. Pollak, Michael H. Baumann, Harald H. Sitte	13
11	Structure–Activity Relationships for Psilocybin, Baeocystin, Aeruginascin, and Related Analogues to Produce Pharmacological Effects in Mice 2022 ·ACS Pharmacology & Translational Science ·Grant C. Glatfelter, Eline Pottie, John S. Partilla, Alexander M. Sherwood, (unknown), (unknown), (unknown), (unknown), (unknown), James A. Golen, Elliott B. Hulley, Christophe P. Stove, A.R. Chadeayne, David R. Manke, Michael H. Baumann	56
12	Characterization of recent non-fentanyl synthetic opioids via three different in vitro µ-opioid receptor activation assays 2022 ·Archives of Toxicology ·Marthe M. Vandeputte, (unknown), Donna Walther, Svante Vikingsson, Robert Kronstrand, Michael H. Baumann, Henrik Gréen, Christophe P. Stove	18
13	Pharmacological evaluation and forensic case series of N-pyrrolidino etonitazene (etonitazepyne), a newly emerging 2-benzylbenzimidazole ‘nitazene’ synthetic opioid 2022 ·Archives of Toxicology ·Marthe M. Vandeputte, Alex J. Krotulski, Donna Walther, Grant C. Glatfelter, Donna M Papsun, Sara E. Walton, Barry K. Logan, Michael H. Baumann, Christophe P. Stove	61
14	Optogenetic brain‐stimulation reward: A new procedure to re‐evaluate the rewarding versus aversive effects of cannabinoids in dopamine transporter‐Cre mice 2021 ·Addiction Biology ·Bree A. Humburg, Chloe J. Jordan, Hai‐Ying Zhang, Hui Shen, Xiao Han, Guo‐Hua Bi, Briana J. Hempel, Ewa Galaj, Michael H. Baumann, Zheng‐Xiong Xi	22
15	Positive Allosteric Modulation of the 5-HT_1A Receptor by Indole-Based Synthetic Cannabinoids Abused by Humans 2020 ·ACS Chemical Neuroscience ·Hideaki Yano, (unknown), (unknown), Alexander F. Hoffman, Michael H. Baumann, Carl R. Lupica, Lei Shi	18
16	Fentanyl-related designer drugs W-18 and W-15 lack appreciable opioid activity in vitro and in vivo 2017 ·JCI Insight ·Xi‐Ping Huang, Tao Che, Thomas J. Mangano, Valerie Le Rouzic, Ying‐Xian Pan, Michael D. Cameron, Michael H. Baumann, Gavril W. Pasternak, Bryan L. Roth	17
17	Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporter 2014 ·Drug and Alcohol Dependence ·Maarten E. A. Reith, Bruce E. Blough, Weimin Hong, Kymry T. Jones, Kyle C. Schmitt, Michael H. Baumann, John S. Partilla, Richard B. Rothman, Jonathan L. Katz	108
18	Alpha-ethyltryptamines as dual dopamine–serotonin releasers 2014 ·Bioorganic & Medicinal Chemistry Letters ·Bruce E. Blough, Antonio Landavazo, John S. Partilla, Ann M. Decker, (unknown), Michael H. Baumann, Richard B. Rothman	29
19	Effects of Intrapleural Heparin or Urokinase on the Extent of Tetracycline-Induced Pleural Disease 1995 ·American Journal of Respiratory and Critical Care Medicine ·Charlie Strange, Michael H. Baumann, Steven A. Sahn, Steven Idell	49
20	Lack of evidence for context-dependent cocaine-induced sensitization in humans: Preliminary studies 1994 ·Pharmacology Biochemistry and Behavior ·Richard B. Rothman, David A. Gorelick, Michael H. Baumann, (unknown), Ronald I. Herning, Wallace B. Pickworth, (unknown), (unknown), (unknown), Jack E. Henningfield	43

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact